Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years

NCT07054099 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

NCT00886613 ·Status: COMPLETED ·Phase: PHASE1

A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)

NCT00322231 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)

NCT01626794 ·Status: WITHDRAWN ·Phase: PHASE3

Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)

NCT00109122 ·Status: COMPLETED ·Phase: PHASE2

Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)

NCT00822237 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

NCT00534248 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013)

NCT01460719 ·Status: COMPLETED ·Phase: PHASE1

Immune Response to Shingles Vaccination

NCT02624375 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)

NCT01527383 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)

NCT01229267 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin

NCT01684072 ·Status: COMPLETED ·Phase: PHASE4

A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)

NCT00231816 ·Status: COMPLETED ·Phase: PHASE3

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age

NCT05084508 ·Status: COMPLETED ·Phase: PHASE2

A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)

NCT02180295 ·Status: WITHDRAWN ·Phase: PHASE3

Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus

NCT05460429 ·Status: UNKNOWN ·Phase: PHASE4

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

NCT00430534 ·Status: COMPLETED ·Phase: PHASE2

Human Immune Responses Smallpox

NCT00068198 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)

NCT03843632 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)

NCT01123941 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)

NCT01254630 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers

NCT00103584 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults

NCT00258947 ·Status: COMPLETED ·Phase: PHASE2

ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)

NCT01600079 ·Status: COMPLETED

Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)

NCT00496327 ·Status: COMPLETED ·Phase: PHASE3